That is a prospective, open-label, two-stage study
That is a prospective, open-label, two-stage study. inside the first thirty days after LT. The scholarly study was created as prospective two-step trial requiring no more than 29 patients. In the first step, 9 patients will be included. If 8 or even more sufferers show no signals of biopsy proved steroid resistant rejection, extra 20…